These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Natural killer activity and antibody-dependent cellular cytotoxicity in patients with non-Hodgkin's lymphoma. Metha BA; Advani SH; Nadkarni SJ Neoplasma; 1988; 35(1):61-8. PubMed ID: 3352838 [TBL] [Abstract][Full Text] [Related]
9. Natural killer cell numbers and cytotoxic activity in pediatric Hodgkin disease. Ikincioğullari A; Doğu F; Babacan E; Oflaz G; Ertem U; Yavuz G; Unal E; Gözdaşoğlu S; Taçyildiz N; Dağdemir A; Cavdar AO Pediatr Hematol Oncol; 2000 Mar; 17(2):133-9. PubMed ID: 10734655 [TBL] [Abstract][Full Text] [Related]
10. Frequent T4-positive cells with cytolytic activity in spleens of patients with Hodgkin's disease (a clonal analysis). Maggi E; Parronchi P; Del Prete G; Ricci M; Bosi A; Moretta L; Romagnani S J Immunol; 1986 Feb; 136(4):1516-20. PubMed ID: 3080527 [TBL] [Abstract][Full Text] [Related]
11. [The effect of sera of breast cancer patients on NK cell activity]. Konjević G; Spuzić I Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436 [TBL] [Abstract][Full Text] [Related]
12. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes. Hillinger SM; Herzig GP J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140 [TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity. Böll B; Eltaib F; Reiners KS; von Tresckow B; Tawadros S; Simhadri VR; Burrows FJ; Lundgren K; Hansen HP; Engert A; von Strandmann EP Clin Cancer Res; 2009 Aug; 15(16):5108-16. PubMed ID: 19671844 [TBL] [Abstract][Full Text] [Related]
14. Increased number of functionally defective large granular lymphocytes in lymphoma patients. Muhonen T; Teerenhovi L; Saksela E Nat Immun Cell Growth Regul; 1987; 6(2):57-64. PubMed ID: 3600676 [TBL] [Abstract][Full Text] [Related]
15. The effect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2 production in Hodgkin's disease. Frydecka I; Boćko D; Kosmaczewska A; Ciszak L; Morilla R Br J Cancer; 2001 May; 84(10):1339-43. PubMed ID: 11355944 [TBL] [Abstract][Full Text] [Related]
16. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption. Laso FJ; Madruga JI; Girón JA; López A; Ciudad J; San Miguel JF; Alvarez-Mon M; Orfao A Hepatology; 1997 May; 25(5):1096-100. PubMed ID: 9141423 [TBL] [Abstract][Full Text] [Related]
17. Cytotoxic activity of lymphocytes from patients with Hodgkin's disease. Holm G; Björkholm M; Mellstedt H; Johansson B Clin Exp Immunol; 1975 Sep; 21(3):376-83. PubMed ID: 1081933 [TBL] [Abstract][Full Text] [Related]
18. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens. Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984 [TBL] [Abstract][Full Text] [Related]
19. Natural killer activity and NK cytotoxic factors in peripheral blood and lymph node cells from non-Hodgkin's lymphoma patients. Nadkarni JJ; Mehta BA; Koppikar SB; Soman CS; Shrikhande SS; Advani SH Neoplasma; 1989; 36(6):701-8. PubMed ID: 2615873 [TBL] [Abstract][Full Text] [Related]
20. Deficient natural killer cell activity in alcoholic cirrhosis. Charpentier B; Franco D; Paci L; Charra M; Martin B; Vuitton D; Fries D Clin Exp Immunol; 1984 Oct; 58(1):107-15. PubMed ID: 6236915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]